logo

Health Care News

Share

PepGen Reports Positive Data From Phase 1 Trial Of PGN-EDO51 For Duchenne Muscular Dystrophy

Ocular Therapeutix Announces Encouraging Interim Results From Phase 1 Trial Of OTX-TKI For Wet AMD

AstraZeneca Says Tezspire Approved In Japan For The Treatment Of Severe Asthma

Atea Pharma Announces FDA Fast Track Designation Granted To AT-752 For Treatment Of Dengue

GSK CFO Iain Mackay To Retire

Roche: Julie Brown To Step Down As Member Of Board

Valneva Provides Further Update On COVID-19 Activities